search
Back to results

The Use of the Prevena Incision Management System (PIMS) on Closed Incisions in Renal Transplant Subjects (PIMS)

Primary Purpose

Surgical Site Reaction

Status
Terminated
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Prevena Incision Management System
Standard of Care for Surgical Incisions
Sponsored by
3M
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Surgical Site Reaction

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Pre-operative Inclusion Criteria

The Subject:

  1. is an adult ≥ 18 years old of either gender
  2. is able to provide their own informed consent Protocol: AHS.2012.Prevena.Cooper.01 v 4.0 Confidential/Property of KCI USA, Inc. Page 6 of 71
  3. will undergo open renal transplant surgery within the next 30 days
  4. will require a surgical incision able to be covered completely by the PIMS dressing
  5. is pre-operatively assessed to undergo a procedure with a CDC Wound Classification of:

    1. Class I (Clean): An uninfected operative wound in which no inflammation is encountered and the respiratory, alimentary, genital, or uninfected urinary tract is not entered

      - OR -

    2. Class II (Clean Contaminated): An operative wound in which the respiratory, alimentary, genital, or uninfected urinary tract are entered under controlled conditions and without unusual contamination
  6. is willing and able to return for all scheduled and required study visits
  7. if female, must test negative on serum pregnancy test
  8. if a female of child-bearing potential, must be willing to utilize an acceptable method of birth control (e.g., birth control pills, condom with spermicide, diaphragm with spermicide, implants, IUD, injections, vaginal rings, hormonal skin patch, etc.) for the duration of study participation
  9. is not concurrently enrolled in a clinical trial which may impact subject health or the surgical incision site

Intra-operative Inclusion Criteria Subjects must meet the following intra-operative inclusion criteria to be eligible for randomization.

The Subject:

  1. continues to meet all pre-operative inclusion criteria
  2. has undergone a Class I or II CDC Wound Classification procedure resulting in a closed surgical incision able to be covered completely by the PIMS dressing

Pre-operative Exclusion Criteria

The Subject:

  1. has a BMI < 18.5 kg/m2 and > 40 kg/m2
  2. has a systemic infection at the time of open renal transplant surgery
  3. has a remote-site skin infection at the time of open renal transplant surgery
  4. is preoperatively assessed to undergo a procedure with a CDC Wound Classification of:

    1. Class III (Contaminated): Open, fresh, accidental wounds, and/or major breaks in sterile technique or gross spillage from the gastrointestinal tract

      - OR -

    2. Class IV (Dirty-Infected): Old traumatic wounds with retained devitalized tissue and those that involve existing clinical infection or perforated viscera
  5. has a known allergy or hypersensitivity to silver, or drape materials that contain acrylic adhesives

Intra-Operative Exclusion Criteria Subjects who meet any of the following intra-operative exclusion criteria are considered screen failures and are not eligible for randomization.

The Subject:

  1. is found to meet any of the pre-operative exclusion criteria
  2. has obvious contamination of the surgical incision
  3. requires external surgical drains that will be covered by the PIMS dressing
  4. is determined to have a CDC Wound Classification of:

    1. Class III (Contaminated): Open, fresh, accidental wounds, and/or major breaks in sterile technique or gross spillage from the gastrointestinal tract

      - OR -

    2. Class IV (Dirty-Infected): Old traumatic wounds with retained devitalized tissue and those that involve existing clinical infection or perforated viscera Protocol: AHS.2012.Prevena.Cooper.01 v 4.0 Confidential/Property of KCI USA, Inc. Page 8 of 71
  5. requires a transfusion, has disseminated-intravascular coagulopathy (DIC) or other medical or surgical conditions during open renal transplant surgery deemed by the Investigator to pose a prohibitively high risk for surgical re-exploration
  6. is deemed unable to continue in the study by the Investigator as the Subject's safety or well-being may be jeopardized.

Sites / Locations

  • MedStar Georgetown University Hospital

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Placebo Comparator

Arm Label

Prevena Incision Management System

Standard of Care for Surgical Incisions

Arm Description

Negative Pressure Therapy Device

Sterile gauze and a non-penetrable barrier

Outcomes

Primary Outcome Measures

Number of Participants With Surgical Site Complications (SSCs)
The primary objective to compare short-term surgical incision-related clinical outcomes in Subjects undergoing open renal transplant surgery when treated with Prevena vs. the standard-of-care wound dressing. Clinical outcomes of interest are defined as Surgical Site Complications (SSCs) that include incisional fluid accumulation (i.e. seroma, hematoma, abscess), dehiscence, surgical site infection (SSI). These outcomes will be compared to a control group consisting of subjects screened for the same inclusion/exclusion criteria but treated with standard-of-care incision dressing.

Secondary Outcome Measures

Full Information

First Posted
April 19, 2011
Last Updated
July 29, 2022
Sponsor
3M
search

1. Study Identification

Unique Protocol Identification Number
NCT01341444
Brief Title
The Use of the Prevena Incision Management System (PIMS) on Closed Incisions in Renal Transplant Subjects
Acronym
PIMS
Official Title
The Use of the Prevena Incision Management System on Closed Recipient Site Incisions in Renal Transplant Subjects
Study Type
Interventional

2. Study Status

Record Verification Date
July 2022
Overall Recruitment Status
Terminated
Why Stopped
Enrollment Difficulties
Study Start Date
August 2013 (undefined)
Primary Completion Date
May 2016 (Actual)
Study Completion Date
May 2016 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
3M

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
This study is being conducted to see how safe and effective the Prevena Incision Management System "Prevena" is when placed over a renal transplantation incision. Prevena provides negative pressure (suction) wound therapy. Prevena will be tested while applied during the time each subject is hospitalized and up to 5 days after the surgery. Prevena is a small portable negative pressure device which consists of a therapy unit that delivers negative pressure. It also includes a dressing system that is intended for use over closed incisions after surgery. The intent of this study is to evaluate Prevena versus the standard care that a doctor would use normally after a kidney transplant.
Detailed Description
This is a randomized, single-center, comparative interventional study looking at the effect of Prevena™ on renal transplant surgical Subjects compared to a control arm treated with the standard-of-care wound dressing. The prospective, post-marketing clinical study described in this protocol will assess the effectiveness and functional performance of PrevenaTM in this clinical indication.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Surgical Site Reaction

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
63 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Prevena Incision Management System
Arm Type
Experimental
Arm Description
Negative Pressure Therapy Device
Arm Title
Standard of Care for Surgical Incisions
Arm Type
Placebo Comparator
Arm Description
Sterile gauze and a non-penetrable barrier
Intervention Type
Device
Intervention Name(s)
Prevena Incision Management System
Intervention Description
It is intended to manage the environment of surgical incisions that continue to drain following sutured or stapled closure by maintaining a closed environment and removing exudate via the application of negative pressure wound therapy (NPWT).
Intervention Type
Other
Intervention Name(s)
Standard of Care for Surgical Incisions
Intervention Description
Sterile 4X4 Non-Penetrable barrier
Primary Outcome Measure Information:
Title
Number of Participants With Surgical Site Complications (SSCs)
Description
The primary objective to compare short-term surgical incision-related clinical outcomes in Subjects undergoing open renal transplant surgery when treated with Prevena vs. the standard-of-care wound dressing. Clinical outcomes of interest are defined as Surgical Site Complications (SSCs) that include incisional fluid accumulation (i.e. seroma, hematoma, abscess), dehiscence, surgical site infection (SSI). These outcomes will be compared to a control group consisting of subjects screened for the same inclusion/exclusion criteria but treated with standard-of-care incision dressing.
Time Frame
62 Days

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Pre-operative Inclusion Criteria The Subject: is an adult ≥ 18 years old of either gender is able to provide their own informed consent Protocol: AHS.2012.Prevena.Cooper.01 v 4.0 Confidential/Property of KCI USA, Inc. Page 6 of 71 will undergo open renal transplant surgery within the next 30 days will require a surgical incision able to be covered completely by the PIMS dressing is pre-operatively assessed to undergo a procedure with a CDC Wound Classification of: Class I (Clean): An uninfected operative wound in which no inflammation is encountered and the respiratory, alimentary, genital, or uninfected urinary tract is not entered - OR - Class II (Clean Contaminated): An operative wound in which the respiratory, alimentary, genital, or uninfected urinary tract are entered under controlled conditions and without unusual contamination is willing and able to return for all scheduled and required study visits if female, must test negative on serum pregnancy test if a female of child-bearing potential, must be willing to utilize an acceptable method of birth control (e.g., birth control pills, condom with spermicide, diaphragm with spermicide, implants, IUD, injections, vaginal rings, hormonal skin patch, etc.) for the duration of study participation is not concurrently enrolled in a clinical trial which may impact subject health or the surgical incision site Intra-operative Inclusion Criteria Subjects must meet the following intra-operative inclusion criteria to be eligible for randomization. The Subject: continues to meet all pre-operative inclusion criteria has undergone a Class I or II CDC Wound Classification procedure resulting in a closed surgical incision able to be covered completely by the PIMS dressing Pre-operative Exclusion Criteria The Subject: has a BMI < 18.5 kg/m2 and > 40 kg/m2 has a systemic infection at the time of open renal transplant surgery has a remote-site skin infection at the time of open renal transplant surgery is preoperatively assessed to undergo a procedure with a CDC Wound Classification of: Class III (Contaminated): Open, fresh, accidental wounds, and/or major breaks in sterile technique or gross spillage from the gastrointestinal tract - OR - Class IV (Dirty-Infected): Old traumatic wounds with retained devitalized tissue and those that involve existing clinical infection or perforated viscera has a known allergy or hypersensitivity to silver, or drape materials that contain acrylic adhesives Intra-Operative Exclusion Criteria Subjects who meet any of the following intra-operative exclusion criteria are considered screen failures and are not eligible for randomization. The Subject: is found to meet any of the pre-operative exclusion criteria has obvious contamination of the surgical incision requires external surgical drains that will be covered by the PIMS dressing is determined to have a CDC Wound Classification of: Class III (Contaminated): Open, fresh, accidental wounds, and/or major breaks in sterile technique or gross spillage from the gastrointestinal tract - OR - Class IV (Dirty-Infected): Old traumatic wounds with retained devitalized tissue and those that involve existing clinical infection or perforated viscera Protocol: AHS.2012.Prevena.Cooper.01 v 4.0 Confidential/Property of KCI USA, Inc. Page 8 of 71 requires a transfusion, has disseminated-intravascular coagulopathy (DIC) or other medical or surgical conditions during open renal transplant surgery deemed by the Investigator to pose a prohibitively high risk for surgical re-exploration is deemed unable to continue in the study by the Investigator as the Subject's safety or well-being may be jeopardized.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Matthew Cooper, MD
Organizational Affiliation
MedStar Georgetown University Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
MedStar Georgetown University Hospital
City
Washington
State/Province
District of Columbia
ZIP/Postal Code
20007
Country
United States

12. IPD Sharing Statement

Learn more about this trial

The Use of the Prevena Incision Management System (PIMS) on Closed Incisions in Renal Transplant Subjects

We'll reach out to this number within 24 hrs